Bio-Connect
Chemical Structure
Chemical Structure
Chemical Structure

Eicosapentaenoic acid [10417-94-4]

Research Use Only
CDX-C0465
Chemodex
CAS Number10417-94-4
Product group Chemicals
Estimated Purity>97%
Molecular Weight302.45
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Chemodex
  • Product Name
    Eicosapentaenoic acid [10417-94-4]
  • Delivery Days Customer
    10
  • CAS Number
    10417-94-4
  • Certification
    Research Use Only
  • Estimated Purity
    >97%
  • Formulation
    Liquid
  • Molecular Formula
    C20H30O2
  • Molecular Weight
    302.45
  • Scientific Description
    Chemical. CAS: 10417-94-4. Formula: C20H30O2. MW: 302.45. Eicosapentaenoic acid (EPA) is one of several omega-3 fatty acids abundantly available in marine organisms. EPA has antioxidant, anti-inflammatory, cardiovascular, anticancer and antiobesity activities. EPA is a polyunsaturated fatty acid (PUFA) that acts as a precursor. When omega-3 fatty acids, like EAP is incorporated into the cell membrane, it induces production of eicosanoids and resolvins which then compete with arachidonic acid for the activity of phospholipase A2. Fatty acids are then liberated inside the cytosol and via cyclooxygenase-2 (COX-2), 5-lipoxygenase and thromboxane synthetase activity get degraded into prostaglandins, leukotrienes, and thromboxanes, responsible for decreasing the synthesis of eicosanoids derived from arachidonic acid (AA), like PGI2, PGF2alpha, PGE2, and LTB4 (pro-inflammatory) and increase the synthesis of LT5, thromboxane-3 and PGE3 (weak effects on inflammation). It has been shown that omega-3 fatty acids potentially exert their anti-inflammatory effect via toll-like receptor 4 (TLR4) pathway and G-protein coupled receptor 120 (GPR120) pathway to inhibit the NF-kappaB and consequently the inflammatory cascade. EPA plays a role in mediating inflammatory processes and immunomodulation for both innate and acquired immune systems and might be interesting vor cytokine storm prevention. EPA has been shown to stimulate ERK1/2 and C/EBPbeta phosphorylation, and induces demethylation of CpG island B in U937 leukemia cells. Attenuates proliferation of U9137 cells, and induces cell cycle arrest and apoptosis in pancreatic cells in vitro. EPA binds and activates PPARalpha and enhances insulin sensitivity. It also has shown positive impacts on gut microbiota flora, leading to its antiobesity and anti-inflammatory activities. EPA has been shown to offer protection against coronary heart disease, thrombosis, ischemic brain injury, scaly dermatitis and some inflammatory diseases. - Eicosapentaenoic acid (EPA) is one of several omega-3 fatty acids abundantly available in marine organisms. EPA has antioxidant, anti-inflammatory, cardiovascular, anticancer and antiobesity activities. EPA is a polyunsaturated fatty acid (PUFA) that acts as a precursor. When omega-3 fatty acids, like EAP is incorporated into the cell membrane, it induces production of eicosanoids and resolvins which then compete with arachidonic acid for the activity of phospholipase A2. Fatty acids are then liberated inside the cytosol and via cyclooxygenase-2 (COX-2), 5-lipoxygenase and thromboxane synthetase activity get degraded into prostaglandins, leukotrienes, and thromboxanes, responsible for decreasing the synthesis of eicosanoids derived from arachidonic acid (AA), like PGI2, PGF2alpha, PGE2, and LTB4 (pro-inflammatory) and increase the synthesis of LT5, thromboxane-3 and PGE3 (weak effects on inflammation). It has been shown that omega-3 fatty acids potentially exert their anti-inflammatory effect via toll-like receptor 4 (TLR4) pathway and G-protein coupled receptor 120 (GPR120) pathway to inhibit the NF-kappaB and consequently the inflammatory cascade. EPA plays a role in mediating inflammatory processes and immunomodulation for both innate and acquired immune systems and might be interesting vor cytokine storm prevention. EPA has been shown to stimulate ERK1/2 and C/EBPbeta phosphorylation, and induces demethylation of CpG island B in U937 leukemia cells. Attenuates proliferation of U9137 cells, and induces cell cycle arrest and apoptosis in pancreatic cells in vitro. EPA binds and activates PPARalpha and enhances insulin sensitivity. It also has shown positive impacts on gut microbiota flora, leading to its antiobesity and anti-inflammatory activities. EPA has been shown to offer protection against coronary heart disease, thrombosis, ischemic brain injury, scaly dermatitis and some inflammatory diseases.
  • SMILES
    CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352200